1. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012; 96:614–618.
2. Blindness C. Vision 2020: the cataract challenge. Community Eye Health. 2000; 13:17–19.
3. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43:69–77.
4. Park SJ, Lee JH, Woo SJ, Ahn J, Shin JP, Song SJ, Kang SW, Park KH; Epidemiologic Survey Committee of the Korean Ophthalmologic Society. Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011. Ophthalmology. 2014; 121:1756–1765.
5. Park SJ, Ahn S, Woo SJ, Park KH. Extent of exacerbation of chronic health conditions by visual impairment in terms of health-related quality of life. JAMA Ophthalmol. 2015; 133:1267–1275.
6. Park SJ, Lee JH, Woo SJ, Kang SW, Park KH; Epidemiologic Survey Committee of Korean Ophthalmologic Society. Five heavy metallic elements and age-related macular degeneration: Korean National Health and Nutrition Examination Survey, 2008-2011. Ophthalmology. 2015; 122:129–137.
7. Yoon KC, Mun GH, Kim SD, Kim SH, Kim CY, Park KH, Park YJ, Baek SH, Song SJ, Shin JP, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011; 25:421–433.
8. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY; The Longitudinal Study of Cataract Study Group. The Lens Opacities Classification System III. Arch Ophthalmol. 1993; 111:831–836.
9. Seah SK, Wong TY, Foster PJ, Ng TP, Johnson GJ. Prevalence of lens opacity in Chinese residents of Singapore: the tanjong pagar survey. Ophthalmology. 2002; 109:2058–2064.
10. Congdon N, Vingerling JR, Klein BE, West S, Friedman DS, Kempen J, O’Colmain B, Wu SY, Taylor HR; Eye Diseases Prevalence Research Group. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004; 122:487–494.
11. Athanasiov PA, Casson RJ, Sullivan T, Newland HS, Shein WK, Muecke JS, Selva D, Aung T. Cataract in rural Myanmar: prevalence and risk factors from the Meiktila Eye Study. Br J Ophthalmol. 2008; 92:1169–1174.
12. Duan XR, Liang YB, Wang NL, Wong TY, Sun LP, Yang XH, Tao QS, Yuan RZ, Friedman DS. Prevalence and associations of cataract in a rural Chinese adult population: the Handan Eye Study. Graefes Arch Clin Exp Ophthalmol. 2013; 251:203–212.
13. Mahdi AM, Rabiu M, Gilbert C, Sivasubramaniam S, Murthy GV, Ezelum C, Entekume G; Nigeria National Blindness and Visual Impairment Study Group. Prevalence and risk factors for lens opacities in Nigeria: results of the national blindness and low vision survey. Invest Ophthalmol Vis Sci. 2014; 55:2642–2651.
14. Foster PJ, Wong TY, Machin D, Johnson GJ, Seah SK. Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol. 2003; 87:1112–1120.
15. Chang JR, Koo E, Agrón E, Hallak J, Clemons T, Azar D, Sperduto RD, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Group. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. Ophthalmology. 2011; 118:2113–2119.
16. Klein R, Klein BE, Jensen SC, Moss SE, Cruickshanks KJ. The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision. The Beaver Dam Eye Study. Ophthalmology. 1994; 101:1969–1979.
17. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998; 126:782–790.
18. Leske MC, Wu SY, Hennis A, Connell AM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology. 1999; 106:35–41.
19. Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schvartz M, Buring JE, Sesso HD, Gaziano JM. Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2014; 121:525–534.
20. Tan JS, Wang JJ, Mitchell P. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study. Ophthalmic Epidemiol. 2008; 15:317–327.
21. Anderson GF. Universal health care coverage in Korea. Health Aff (Millwood). 1989; 8:24–34.
22. Erie JC, Baratz KH, Hodge DO, Schleck CD, Burke JP. Incidence of cataract surgery from 1980 through 2004: 25-year population-based study. J Cataract Refract Surg. 2007; 33:1273–1277.
23. Lansingh VC, Resnikoff S, Tingley-Kelley K, Nano ME, Martens M, Silva JC, Duerksen R, Carter MJ. Cataract surgery rates in latin america: a four-year longitudinal study of 19 countries. Ophthalmic Epidemiol. 2010; 17:75–81.
24. International Federation of Health Plans (GB). 2012 Comparative price report. accessed on 3 March 2014. Available at
http://www.ifhp.com.
25. Roy CN. Anemia of inflammation. Hematology Am Soc Hematol Educ Program. 2010; 2010:276–280.
26. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004; 104:2263–2268.
27. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352:1011–1023.
28. Girdhar A, Kumar V, Singh A, Menon B, Vijayan VK. Systemic inflammation and its response to treatment in patients with asthma. Respir Care. 2011; 56:800–805.
29. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012; 142:86–93.
30. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007; 120:S94–138.
31. Weatherall M, Clay J, James K, Perrin K, Shirtcliffe P, Beasley R. Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology. 2009; 14:983–990.
32. Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buring JE, Hennekens CH. Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians. Ophthalmic Epidemiol. 1998; 5:133–142.
33. Cumming RG, Mitchell P. Medications and cataract. The Blue Mountains Eye Study. Ophthalmology. 1998; 105:1751–1758.
34. Rim TH, Kim MH, Kim WC, Kim TI, Kim EK. Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008-2010. BMC Ophthalmol. 2014; 14:4.